OTCMKTS:WILYY

Demant A/S Stock Forecast, Price & News

$19.73

+0.13 (+0.66 %)

(As of 01/25/2021 05:19 PM ET)

Add

Compare

Today's Range

$19.45

Now: $19.73▼

$19.73

50-Day Range

$17.88

MA: $18.13▼

$18.75

52-Week Range

$11.17

Now: $19.73▼

$19.73

Volume756 shs

Average Volume1,482 shs

Market Capitalization$9.50 billion

P/E Ratio43.84

Dividend YieldN/A

Beta0.23

Demant A/S, a hearing healthcare company, develops, manufactures, and sells products and equipment to enhance people's hearing in Europe, North America, the Pacific, Asia, and internationally. Its products include hearing devices and implants; diagnostic products; and communication systems, such as headsets and solutions for the professional call center and office market, as well as headsets for the gaming and mobile music segments. The company was formerly known as William Demant Holding A/S and changed its name to Demant A/S in March 2019. Demant A/S was founded in 1904 and is headquartered in SmÃ¸rum, Denmark.

MarketRank^™

Overall MarketRank^™

0.76 out of 5 stars

Medical Sector

1145th out of 1,922 stocks

Surgical Appliances & Supplies Industry

29th out of 40 stocks

0.0 Analyst's Opinion

Consensus Rating
There is not enough analysis data for Demant A/S.

1.9 Community Rank

Outperform Votes
Demant A/S has received 182 “outperform” votes. (Add your “outperform” vote.)
Underperform Votes
Demant A/S has received 293 “underperform” votes. (Add your “underperform” vote.)
Community Sentiment
Demant A/S has received 61.68% “underperform” votes from our community.

MarketBeat's community ratings are surveys of what our community members think about Demant A/S and other stocks. Vote “Outperform” if you believe WILYY will outperform the S&P 500 over the long term. Vote “Underperform” if you believe WILYY will underperform the S&P 500 over the long term. You may vote once every thirty days.

0.0 Dividend Strength

Dividend Yield
Demant A/S does not currently pay a dividend.
Dividend Growth
Demant A/S does not have a long track record of dividend growth.

0.0 Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Demant A/S insiders have not sold or bought any company stock.

1.9 Earnings and Valuation

Earnings Growth
Earnings for Demant A/S are expected to grow by 186.96% in the coming year, from $0.23 to $0.66 per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of Demant A/S is 43.56, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 24.32.
Price to Earnings Ratio vs. Sector
The P/E ratio of Demant A/S is 43.56, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 36.62.
Price to Book Value per Share Ratio
Demant A/S has a P/B Ratio of 8.38. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

Industry, Sector and Symbol

Stock Exchange OTCMKTS

Industry Surgical appliances & supplies

Sub-IndustryN/A

SectorMedical

Current SymbolOTCMKTS:WILYY

Previous SymbolNASDAQ:WILYY

CUSIPN/A

CIKN/A

Webwww.demant.com

Phone45-3917-7300

Employees15,678

Year FoundedN/A

Debt

Debt-to-Equity Ratio0.33

Current Ratio0.68

Quick Ratio0.47

Price-To-Earnings

Trailing P/E Ratio43.84

Forward P/E Ratio85.78

P/E GrowthN/A

Sales & Book Value

Annual Sales$2.24 billion

Price / Sales4.24

Cash Flow$0.54 per share

Price / Cash Flow36.48

Book Value$2.34 per share

Price / Book8.43

Profitability

EPS (Most Recent Fiscal Year)N/A

Net IncomeN/A

Net MarginsN/A

Return on EquityN/A

Return on AssetsN/A

Miscellaneous

Outstanding Shares481,382,000

Market Cap$9.50 billion

Next Earnings Date2/2/2021 (Estimated)

OptionableNot Optionable

$19.73

+0.13 (+0.66 %)

(As of 01/25/2021 05:19 PM ET)

30 days | 90 days | 365 days | Advanced Chart

Receive WILYY News and Ratings via Email

Sign-up to receive the latest news and ratings for WILYY and its competitors with MarketBeat's FREE daily newsletter.

Demant A/S (OTCMKTS:WILYY) Frequently Asked Questions

How has Demant A/S's stock price been impacted by COVID-19 (Coronavirus)?

Demant A/S's stock was trading at $16.10 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, WILYY stock has increased by 22.5% and is now trading at $19.73.
View which stocks have been most impacted by COVID-19.

Is Demant A/S a buy right now?

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Demant A/S in the last twelve months. There are currently 1 sell rating and 2 hold ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" Demant A/S stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in WILYY, but not buy additional shares or sell existing shares.
View analyst ratings for Demant A/S or view MarketBeat's top 5 stock picks.

What stocks does MarketBeat like better than Demant A/S?

Wall Street analysts have given Demant A/S a "Hold" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Demant A/S wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

When is Demant A/S's next earnings date?

Demant A/S is scheduled to release its next quarterly earnings announcement on Tuesday, February 2nd 2021.
View our earnings forecast for Demant A/S.

Who are some of Demant A/S's key competitors?

Some companies that are related to Demant A/S include Zimmer Biomet (ZBH), Coloplast A/S (CLPBY), Smith & Nephew (SNN), STERIS (STE), Wound Management Technologies (WNDM), Shandong Weigao Group Medical Polymer (SHWGF), MSA Safety (MSA), Eargo (EAR), Avanos Medical (AVNS), Establishment Labs (ESTA), Inogen (INGN), Invacare (IVC), Sanara MedTech (SMTI), Sientra (SIEN) and Lakeland Industries (LAKE).
View all of WILYY's competitors.

Who are Demant A/S's key executives?

Demant A/S's management team includes the following people:

Mr. SÃ¸ren Nielsen, CEO, Pres & Member of Exec. Board (Age 50)
Mathias Holten MÃ¸ller, Director of Investor Relations
Ms. Trine Kromann-Mikkelsen, VP of Corp. Communication & Relations
Mr. Finn Mohring, Sr. VP of R&D
Mr. Jes Olsen, Pres of Oticon Medical
Mr. Christian Lange, Investor Relations Officer

What is Demant A/S's stock symbol?

Demant A/S trades on the OTCMKTS under the ticker symbol "WILYY."

How do I buy shares of Demant A/S?

Shares of WILYY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Demant A/S's stock price today?

One share of WILYY stock can currently be purchased for approximately $19.73.

How big of a company is Demant A/S?

Demant A/S has a market capitalization of $9.50 billion and generates $2.24 billion in revenue each year. The company earns $219.15 million in net income (profit) each year or $0.45 on an earnings per share basis. Demant A/S employs 15,678 workers across the globe.

What is Demant A/S's official website?

The official website for Demant A/S is www.demant.com.

How can I contact Demant A/S?

Demant A/S's mailing address is Kongebakken 9, Smorum G7, 2765. The company can be reached via phone at 45-3917-7300 or via email at [email protected]

This page was last updated on 1/25/2021 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here